Univariate Cox regression analysis of OS, DSS, PFI, and DFI revealed that LAPTM4B served as a significant risk factor for patients in multiple cancer types, including LIHC, B-ALL, SARC, GBMLGG, SKCM, AML, ACC, UVM, CESC, HNSC, KICH, MESO, UVM, BRCA, and PCPG (Figure 2A). Here, LAPTM4B is linked to acute myeloid leukemia.